New Formulation of FDA-Approved Drug Shows Encouraging Results for...

Notalgia paresthetica—a nerve disorder characterized by a persistent itch in the upper back—is a common and underdiagnosed condition worldwide. To date, there are no FDA-approved treatments...(PRWeb February 09, 2023)Read the full story at https://www.prweb.com/releases/new_formulation_of_fda_approved_drug_shows_encouraging_results_for_treating_a_common_itch_condition_in_phase_2_clinical_trial/prweb19161473.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news